Indegene Ltd Subsidiary to Acquire BioPharm Parent Holding, Inc. for Up to USD 106 Million

Indegene Ltd's wholly owned subsidiary, Indegene Ireland Limited, has signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in BioPharm Parent Holding, Inc. along with its subsidiaries for an amount not exceeding USD 106 Million, subject to cash/net working capital adjustments. BioPharm, a Marketing and Communications Agency, provides data-driven healthcare provider marketing solutions for Life Sciences clients and reported revenues of USD 38.13 Million in the financial year ending December 2024. The acquisition is expected to be completed by 1st October 2025, and is part of Indegene's strategy to augment its capabilities and offerings in the omnichannel marketing agency business.